Shenzhen Salubris Pharmaceuticals has said that it plans to invest up to CNY200 million (US$32.3 million) in a start-up life insurance venture with a partner.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »
Brought to you by